GlassScriptPhysician profile
Denise Hinton
NPI 1518473693
$1,560.93
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $554 · 2022: $553 · 2023: $353 · 2024: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $579.20 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $128.59 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $105.04 | 2021-2022 | |
| Cardiva Medical, INC. | $92.63 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cvrx, INC. | $91.08 | 2022-2023 | Barostim Neo System |
| Philips North America LLC | $86.38 | 2023 | |
| Merck Sharp & Dohme LLC | $74.28 | 2021-2022 | |
| Pfizer INC. | $59.70 | 2022-2023 | |
| Abiomed | $41.63 | 2024 | Impella |
| Alnylam Pharmaceuticals INC. | $39.17 | 2024 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $38.40 | 2022-2023 | Camzyos |
| Novo Nordisk INC | $34.29 | 2021 | |
| Veryan Medical Incorporated | $28.67 | 2022 | |
| Medtronic, INC. | $26.80 | 2023 | Venaseal |
| Melinta Therapeutics, LLC | $23.12 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.23 | 2022 | |
| Daiichi Sankyo INC. | $20.95 | 2024 | Injectafer |
| Edwards Lifesciences Corporation | $20.77 | 2021 | |
| Medicomp INC | $16.68 | 2022 | |
| Avion Pharmaceuticals | $13.51 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.40 | 2022 | |
| Cardiovascular Systems INC. | $5.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Hinton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.